B&H MED

B&H MED specializes in the R&D and innovation of self-administration devices for the medical sector, dedicated to providing high-end, comprehensive self-administration solutions to global clients. Bringing together top industry talent, the company possesses integrated service capabilities covering the entire process—from drug development to clinical application—for self-administration instruments and device systems. As a leading enterprise in China—and the first to simultaneously possess capabilities for injection pen R&D, the development of automated mass-production equipment solutions, and proprietary intellectual property—B&H MED has successfully developed products such as LoonGBIOPen® and Beinghigher®. These disposable injection pens are compatible with a wide range of pre-filled injectable drugs and suitable for diverse application scenarios; the company has already established R&D and validation partnerships with numerous renowned pharmaceutical firms. Notably, LoonGBIOPen® has secured letters of intent for orders totaling tens of millions of units. Upholding a philosophy of "pursuing excellence, delivering value, and achieving win-win cooperation," B&H MED has established sales and technical service centers across China and overseas. The company continues to drive innovation in smart self-administration products and advance its internationalization strategy, contributing to the continuous progress of global healthcare.